South Korea · Delayed Price · Currency is KRW Ildong Pharmaceutical Statistics
Total Valuation
KRX:249420 has a market cap or net worth of KRW 1.19 trillion. The enterprise value is 1.28 trillion.
| Market Cap | 1.19T |
| Enterprise Value | 1.28T |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
KRX:249420 has 31.51 million shares outstanding. The number of shares has increased by 2.17% in one year.
| Current Share Class | 31.51M |
| Shares Outstanding | 31.51M |
| Shares Change (YoY) | +2.17% |
| Shares Change (QoQ) | +7.46% |
| Owned by Insiders (%) | 2.11% |
| Owned by Institutions (%) | 3.24% |
| Float | 20.60M |
Valuation Ratios
The trailing PE ratio is 38.38 and the forward PE ratio is 27.59.
| PE Ratio | 38.38 |
| Forward PE | 27.59 |
| PS Ratio | 2.06 |
| PB Ratio | 5.07 |
| P/TBV Ratio | 5.68 |
| P/FCF Ratio | 177.71 |
| P/OCF Ratio | 56.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.92, with an EV/FCF ratio of 192.34.
| EV / Earnings | 45.98 |
| EV / Sales | 2.23 |
| EV / EBITDA | 29.92 |
| EV / EBIT | 67.95 |
| EV / FCF | 192.34 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.66.
| Current Ratio | 0.94 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 3.63 |
| Debt / FCF | 23.28 |
| Interest Coverage | 1.34 |
Financial Efficiency
Return on equity (ROE) is 10.56% and return on invested capital (ROIC) is 5.72%.
| Return on Equity (ROE) | 10.56% |
| Return on Assets (ROA) | 2.01% |
| Return on Invested Capital (ROIC) | 5.72% |
| Return on Capital Employed (ROCE) | 5.55% |
| Weighted Average Cost of Capital (WACC) | 9.96% |
| Revenue Per Employee | 542.56M |
| Profits Per Employee | 26.32M |
| Employee Count | 1,061 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 3.76 |
Taxes
In the past 12 months, KRX:249420 has paid 606.45 million in taxes.
| Income Tax | 606.45M |
| Effective Tax Rate | 2.81% |
Stock Price Statistics
The stock price has increased by +219.07% in the last 52 weeks. The beta is 1.07, so KRX:249420's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +219.07% |
| 50-Day Moving Average | 38,268.00 |
| 200-Day Moving Average | 25,190.65 |
| Relative Strength Index (RSI) | 50.88 |
| Average Volume (20 Days) | 461,408 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:249420 had revenue of KRW 575.66 billion and earned 27.92 billion in profits. Earnings per share was 980.93.
| Revenue | 575.66B |
| Gross Profit | 222.90B |
| Operating Income | 18.75B |
| Pretax Income | 21.56B |
| Net Income | 27.92B |
| EBITDA | 42.77B |
| EBIT | 18.75B |
| Earnings Per Share (EPS) | 980.93 |
Balance Sheet
The company has 59.74 billion in cash and 155.42 billion in debt, with a net cash position of -95.69 billion or -3,036.97 per share.
| Cash & Cash Equivalents | 59.74B |
| Total Debt | 155.42B |
| Net Cash | -95.69B |
| Net Cash Per Share | -3,036.97 |
| Equity (Book Value) | 234.06B |
| Book Value Per Share | 7,366.03 |
| Working Capital | -13.82B |
Cash Flow
In the last 12 months, operating cash flow was 20.93 billion and capital expenditures -14.26 billion, giving a free cash flow of 6.68 billion.
| Operating Cash Flow | 20.93B |
| Capital Expenditures | -14.26B |
| Free Cash Flow | 6.68B |
| FCF Per Share | 211.87 |
Margins
Gross margin is 38.72%, with operating and profit margins of 3.26% and 4.85%.
| Gross Margin | 38.72% |
| Operating Margin | 3.26% |
| Pretax Margin | 3.74% |
| Profit Margin | 4.85% |
| EBITDA Margin | 7.43% |
| EBIT Margin | 3.26% |
| FCF Margin | 1.16% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 0.22% |
| Buyback Yield | -2.17% |
| Shareholder Yield | -1.61% |
| Earnings Yield | 2.35% |
| FCF Yield | 0.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 5, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Mar 5, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
KRX:249420 has an Altman Z-Score of 2.06 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.06 |
| Piotroski F-Score | 6 |